DUBLIN--(BUSINESS WIRE)--Apr 15, 2019--The "Colorectal Cancer Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report is a business analysis that examines market trends for colorectal cancer therapeutics.

This report captures colorectal cancer therapeutics market revenue for different regions by treatment type, i.e., chemotherapy, targeted therapy and immunotherapy used for treating the disease. A detailed colorectal cancer therapeutics market analysis covers the regions of North America, Europe, Asia-Pacific, and Rest of World.

Market values are provided using 2017 as base year, 2018 as estimated year, and 2023 as forecasted year. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

The report includes sections on the following topics:

  • Current prevalence of colorectal cancer, trend analysis and factors influencing future incidence
  • Market analysis by treatment type, including annual incidence and trend analysis
  • Risk factors and other drivers that may impact the future incidence of colorectal cancer
  • Review of the major market opportunities by identifying specific high-growth and emerging market opportunities
  • Market share and information on key market players
  • Analysis and forecast of the revenues for colorectal cancer treatment for the global market, major market sub-segments subdivided by geographic region and further, by selected country
  • Detailed review of the current products, their indications for all identified market segments
  • Profile of the individual market sub-segments within the major market segments analyzed and the distinguishing features of each of the market sub-segments

The report includes:

  • 39 data tables and 18 additional tables
  • Detailed overview of the colorectal cancer (CRC) therapeutics and corresponding global markets
  • Country specific data and analysis for France, Germany, Italy, U.K., Spain, Russia, India, China, Japan, United States, Canada, Middle East and Africa
  • Evaluation of market dynamics with a focus on increasing prevalence of colorectal cancer cases, technological advancements in radiology and chemotherapy, and increasing cancer prevention initiatives
  • Coverage of some of the significant CRC tests including CT colonography, double-contrast barium enema, and biopsy test and their usability study and future growth potential
  • A look into regulatory environment, new products launches and technological advancements, and current strategies within the market
  • Company profiles of major manufacturers and suppliers of CRC therapeutic drugs, including Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co, Pfizer and Sanofi

Key Topics Covered

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Overview and Biology

  • Introduction
  • Market Definition and Overview
  • Incidence
  • Stages of Colorectal Cancer
  • Stage 0
  • Stage I
  • Stage II
  • Stage III
  • Stage IV
  • Standard Treatment Options for Stage IV and Recurrent Colon Cancer
  • Epidemiology of Colorectal Cancer
  • Etiology
  • Genetic Factors
  • Environmental Factors
  • Pathophysiology
  • Risk Factors
  • Inherited Syndromes
  • Symptoms
  • Metastasis
  • Diagnosis
  • Colonoscopy
  • Biopsy
  • Laboratory Tests
  • CT Scan
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Others
  • Prognosis
  • Blockbuster Drugs
  • Avastin
  • Opdivo
  • Cetuximab (Erbitux)
  • End-Users
  • Hospitals
  • Cancer Research Laboratories
  • Primary Healthcare and Community Health Centers
  • Others

Chapter 4 Colorectal Cancer Market Dynamics

  • Market Drivers
  • Increasing Cancer Prevalence Rates
  • Increasing Geriatric Population
  • Outreach Programs Raise Cancer Awareness
  • Cancer and Treatment Technologies
  • Increasing Adoption of Combination and Targeted Therapies
  • Market Restraints
  • Drug Patent Expiries and Generic Drugs Emergence
  • High Costs of The Screening Associated with The Drugs
  • Lack of Awareness in Underdeveloped Countries

Chapter 5 Pipeline Analysis

  • Research and Development Overview
  • New Product Development
  • Phase I Clinical Trials
  • Phase II Clinical Trial
  • Phase III Clinical Trials
  • Impact on Market

Chapter 6 Global Colorectal Cancer Therapeutics Market Breakdown by Treatment Type

  • Market Size and Forecast
  • Chemotherapy
  • Overview
  • Neoadjuvant Chemotherapy
  • Adjuvant Chemotherapy
  • Systemic Chemotherapy
  • Regional Chemotherapy
  • First-Line Chemotherapy and Targeted Therapy
  • Side Effects
  • Second-Line Chemotherapy
  • Treatment of Liver Metastasis
  • Market Size and Forecast
  • Immunotherapy
  • Overview
  • Side Effects
  • Market Size and Forecast
  • Targeted Therapy
  • Overview
  • Targeted Chemotherapy Agents
  • Monoclonal Antibody Therapy
  • Tyrosine Kinase Inhibitors (TKIs)
  • Side Effects
  • Market Size and Forecast
  • Conventional Treatment Options
  • Surgery

Chapter 7 Global Colorectal Cancer Therapeutics Market Breakdown by Region

  • Introduction
  • Market Size and Forecast
  • North America
  • Market Size and Forecast
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Market Drivers
  • Market Restraints
  • Market Size and Forecast
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Market Size and Forecast
  • Market Drivers
  • Market Restraints
  • Japan
  • India
  • China
  • Rest of Asia-Pacific
  • Rest of World
  • Market Size and Forecast

Chapter 8 Regulatory and Reimbursement Structure

  • Overview of Regulations
  • United States
  • Canada
  • Europe
  • Japan
  • China
  • Overview of Pricing and Reimbursement
  • United States
  • Europe
  • Japan

Chapter 9 Competitive Landscape and Key Developments

  • Overview
  • Bristol-Meyers Squibb
  • Roche
  • Key Developments, 2017-2019
  • Mergers and Acquisitions
  • New Product Launch
  • Agreement, Collaboration and Partnerships

Chapter 10 Company Profiles

  • Abbvie
  • Abbott Laboratories
  • Amgen
  • Astrazeneca PLC
  • Bayer Healthcare
  • Bristol-Myers Squibb
  • Eli Lilly and Co.
  • F Hoffman-La Roche Ltd.
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/mrlv8n

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Colon Cancer Drugs

KEYWORD: EUROPE NORTH AMERICA

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/15/2019 05:19 AM/DISC: 04/15/2019 05:19 AM

Copyright Business Wire 2019.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

PLEASE BE ADVISED: Soon we will no longer integrate with Facebook for story comments. The commenting option is not going away, however, readers will need to register for a FREE site account to continue sharing their thoughts and feedback on stories. If you already have an account (i.e. current subscribers, posting in obituary guestbooks, for submitting community events), you may use that login, otherwise, you will be prompted to create a new account.

Load comments